Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

49.900
+1.0602.17%
Volume:24.71M
Turnover:1.22B
Market Cap:206.84B
PE:36.86
High:50.350
Open:48.860
Low:48.180
Close:48.840
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.64
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.38%
ROA:7.60%
PB:3.69
PE(LYR):36.86
PS:7.51

Loading ...

Wuxi Biologics’ MFG8 Drug Substance Plant Passes FDA Pre-license Inspection

Reuters
·
Jul 09

Movement Alert|WuXi Biologics Rises 3.03% in Regular Trading, Sector Rebound Combined with Sustained High-Frequency Buybacks Boost Confidence

Market Focus
·
Jul 09

Movement Alert|WuXi Biologics Declines 3.05% in Regular Trading, Life Sciences Sector Weakens for Second Consecutive Day

Market Focus
·
Jul 08

Wuxi Biologics Retains MSCI ESG AAA Rating for Fourth Straight Year Under Model 5.0

Reuters
·
Jul 08

WuXi Biologics lifts share capital by 0.005%, repurchases 2.72 million shares for HK$99.82 million; cumulative buy-backs reach HK$1.27 billion

Bulletin Express
·
Jul 07

WUXI BIO Executes Major Share Buyback on July 7

Stock News
·
Jul 07

Wuxi Biologics Files HKEX Next-day Disclosure Showing 206,000 New Shares Issued Via Option Exercises

Reuters
·
Jul 07

Wuxi Biologics (cayman) Stock Falls 2.7% in Hong Kong

Dow Jones
·
Jul 07

Movement Alert|WuXi Biologics Falls 3.02% in Regular Trading, Trading at HKD 36.68

Market Focus
·
Jul 07

WUXI BIO Issues 2.45 Million New Shares in June; Authorized Capital Steady, Public Float Intact

Bulletin Express
·
Jul 06

Movement Alert|WuXi Biologics Rises 3.09% in Regular Trading, Sustained High-Frequency Buybacks and Sector Strength Drive Gains

Market Focus
·
Jul 06

Is WuXi Biologics (Cayman) (SEHK:2269) Undervalued On ANVISA GMP Approval?

Simply Wall St.
·
Jul 03

Wuxi XDC Files HKEX Next-day Disclosure Return, Issues 263,203 New Shares to Lift Share Capital

Reuters
·
Jul 03

Movement Alert|WuXi Biologics Rises 3.4% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence

Market Focus
·
Jul 03

Wuxi XDC Files HKEX Next-day Disclosure Return, Share Capital Rises by 279,500 Shares

Reuters
·
Jul 02

Wuxi Biologics (cayman) Stock Climbs 3.6% in Hong Kong

Dow Jones
·
Jul 02

Movement Alert|WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence

Market Focus
·
Jul 02

Wuxi Biologics Next-day Disclosure Return Flags 642,200 New Shares Issued on HKEX

Reuters
·
Jun 30

Wuxi Biologics (cayman) Stock Slips 1.9% in Hong Kong

Dow Jones
·
Jun 30

Wuxi Biologics Wins Anvisa GMP Certification for Wuxi Manufacturing Sites

Reuters
·
Jun 30